Clinitech Laboratory Fund Raise of ₹5.78 Cr

Clinitech Laboratory Board Meeting Date

Clinitech Laboratory intimated BSE of a board meeting on 13 November 2026 to approve unaudited half-year results and note an internal audit report. The trading window stays closed until 48 hours after the results.

Clinitech Laboratory Other Announcement

Clinitech Laboratory submitted a certificate confirming the non-applicability of SEBI Regulation 23 regarding Related Party Transactions. This is for the half-year ended September 30, 2026.

Clinitech Laboratory Promoter Reclassification

Clinitech Laboratory Ltd reclassified 12,000 shares held by Mr. Siddhesh Nayak on behalf of Kamaxi Stock Trendz from 'Public' to 'Promoter Group' category.

Clinitech Laboratory Other Announcement

Clinitech Laboratory Limited filed a Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming no rematerialization requests were received.

Clinitech Laboratory Annual General Meeting

Clinitech Laboratory Limited held its 16th Annual General Meeting on September 24, 2026. Shareholders transacted items including financial statement adoption and director re-appointment.

Clinitech Laboratory Annual General Meeting

Clinitech Laboratory Limited has released its Annual Report for FY 2025-26 and notice for the Annual General Meeting to be held on September 24, 2026.

Om Metallogic Fund Raise

Om Metallogic Ltd intimated a board meeting on 14 November 2026 to approve rights issue issue price, entitlement ratio, record date and issue dates. The rights issue follows BSE in-principle approval.

Virinchi Fund Raise of ₹30 Cr

Virinchi's board approved a Rs 30 Crore preferential issue of 2 crore convertible warrants at Rs 15 each. Subject to EGM approval, allottees include promoter Viswanath Kompella.

Value

₹30.00 Cr

Execution

Warrant tenure not exceeding 18 months from allotment

IIFL Finance Fund Raise of ₹6,414 Cr

IIFL Finance's board approved a preferential issue of convertible preference shares and warrants worth Rs.6,414.20 Crore. Shareholder approval is needed at a 4 December EGM.

Value

₹6,414 Cr

Bajaj Finance Fund Raise of ₹5,800 Cr

Bajaj Finance's special committee approved issuing 5.74 crore warrants to promoter Bajaj Finserv at ₹1,010 each. The issue raises about ₹5,800 crore.

Value

₹5,800 Cr

Cholamandalam Investment & Finance Company Fund Raise of ₹5,000 Cr

Cholamandalam Investment sent shareholders a postal ballot notice seeking approval for a Rs 5,000 crore QIP. E-voting runs November 10 to December 9, 2026.

Value

₹5,000 Cr

Execution

Allotment to be completed within 365 days of shareholder approval

HB Leasing & Finance Co Fund Raise

HB Leasing's board discussed fund-raising options on November 9, 2026, including equity and preference shares. No quantum or pricing is decided; advisers will be consulted.